ARMISTICE CAPITAL, LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Senti Biosciences, Inc. Class A Common Stock, par value $0.0001 per share (SNTI)

Filing Manager
ARMISTICE CAPITAL, LLC
Reporting Manager
Armistice Capital, LLC
Security
Senti Biosciences, Inc. Class A Common Stock, par value $0.0001 per share
Symbol
SNTI
Shares outstanding
28,853,948 shares
Disclosed Ownership
1,439,812 shares
Ownership
5%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 15:53:30 UTC
Date of event
31 Mar 2025
Previous filing
14 Feb 2025
SEC
View on sec.gov

Quoteable Key Fact

"ARMISTICE CAPITAL, LLC disclosed 5% ownership in Senti Biosciences, Inc. Class A Common Stock, par value $0.0001 per share (SNTI) on 31 Mar 2025."

Quick Takeaways

  • ARMISTICE CAPITAL, LLC filed SCHEDULE 13G/A for Senti Biosciences, Inc. Class A Common Stock, par value $0.0001 per share (SNTI).
  • Disclosed ownership: 5%.
  • Date of event: 31 Mar 2025.

What Changed

  • Previous schedule filing date: 14 Feb 2025.
  • Current filing was accepted on 15 May 2025, 15:53.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Armistice Capital, LLC 5% 1,439,812 0 1,439,812 /s/ Steven Boyd Steven Boyd - Managing Member
Steven Boyd 5% 1,439,812 0 1,439,812 /s/ Steven Boyd Steven Boyd